OBJECTIVE: The authors performed a longitudinal study of the effects on thalamic volume of switching from typical to atypical antipsychotic medications. METHOD: Magnetic resonance imaging scans were acquired from 10 subjects with chronic schizophrenia taking typical antipsychotics and 20 healthy volunteers. Subjects with schizophrenia were switched to olanzapine; both groups were rescanned. RESULTS: At baseline, thalamic volumes in subjects with chronic schizophrenia were 5.8% greater than those of healthy volunteers. At follow-up, there was no significant difference between groups. Additional analysis revealed a significant positive correlation between baseline thalamic volume and dosage of typical antipsychotic medication. Higher dosages at baseline were correlated with larger reductions in volume after the switch to olanzapine. CONCLUSIONS: Antipsychotic medication effects may be a factor in the wide range of thalamic volume differences reported between subjects with schizophrenia and healthy volunteers.
OBJECTIVE: The authors performed a longitudinal study of the effects on thalamic volume of switching from typical to atypical antipsychotic medications. METHOD: Magnetic resonance imaging scans were acquired from 10 subjects with chronic schizophrenia taking typical antipsychotics and 20 healthy volunteers. Subjects with schizophrenia were switched to olanzapine; both groups were rescanned. RESULTS: At baseline, thalamic volumes in subjects with chronic schizophrenia were 5.8% greater than those of healthy volunteers. At follow-up, there was no significant difference between groups. Additional analysis revealed a significant positive correlation between baseline thalamic volume and dosage of typical antipsychotic medication. Higher dosages at baseline were correlated with larger reductions in volume after the switch to olanzapine. CONCLUSIONS: Antipsychotic medication effects may be a factor in the wide range of thalamic volume differences reported between subjects with schizophrenia and healthy volunteers.
Authors: Michelle Y Deng; Gráinne M McAlonan; Charlton Cheung; Cindy P Y Chiu; Chi W Law; Vinci Cheung; Pak C Sham; Eric Y H Chen; Siew E Chua Journal: Psychopharmacology (Berl) Date: 2009-07-30 Impact factor: 4.530
Authors: Anna E Ordóñez; Frances F Loeb; Xueping Zhou; Lorie Shora; Rebecca A Berman; Diane D Broadnax; Peter Gochman; Siyuan Liu; Judith L Rapoport Journal: J Am Acad Child Adolesc Psychiatry Date: 2016-07-01 Impact factor: 8.829
Authors: Fulvio A Scorza; Andrea Schmitt; Roberta M Cysneiros; Ricardo M Arida; Esper A Cavalheiro; Wagner F Gattaz Journal: Clinics (Sao Paulo) Date: 2010-05 Impact factor: 2.365
Authors: Joyce Y Guo; Sanna Huhtaniska; Jouko Miettunen; Erika Jääskeläinen; Vesa Kiviniemi; Juha Nikkinen; Jani Moilanen; Marianne Haapea; Pirjo Mäki; Peter B Jones; Juha Veijola; Matti Isohanni; Graham K Murray Journal: Schizophr Res Date: 2015-07-16 Impact factor: 4.939